In in vivo models, combination radiotherapy and PTT mediated via these particles in addition to anti-PDL1 therapy also resulted in drastic decreases in primary tumor volume, as well as an increase in CD4+ and CD8+ T cells in the tumor microenvironment and immune memory effect, which inhibited tumor growth after a secondary inoculation (Figure 3b). The gene discussed is CD8A; the disease is neoplasm.